세계의 단일세포 게노믹스 및 프로테오믹스 시장(-2023년)
Global Single Cell Genomics and Proteomics Market, Forecast to 2023
상품코드 : 911378
리서치사 : Frost & Sullivan
발행일 : 2019년 09월
페이지 정보 : 영문 71 Pages
US $ 1,500 ₩ 1,771,000
Web Access (Regional License) help
리서치사의 웹사이트에 로그인할 수 있는 패스워드가 발급되며, PDF를 다운로드 받는 형태로 제공됩니다. 동일 국가 내에 있는 사업장의 모든 분들이 이용할 수 있는 라이선스이며, 이용 인원수 제한은 없습니다. 텍스트 등의 PDF 내용 편집은 불가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


한글목차

세계의 단일세포 게노믹스 및 프로테오믹스(Single Cell Genomics and Proteomics) 시장을 조사했으며, 주요 동향·시장 성장에 대한 각종 영향요인 분석, 주요 기술과 워크플로우, 용도·기술·워크플로우별 매출 예측, 미충족 요구와 과제, 단일세포 기술의 전망, 향후 용도, 주목 기업·기술, 성장 기회·성공 전략 분석 등을 정리하여 전해드립니다.

개요

시장 성장 촉진요인·억제요인

경쟁 환경

자금조달 동향

성장 기회·권장 행동

매출 예측

미충족 요구·향후 도입 부문

향후 전망

부록

FROST & SULLIVAN 소개

KSA 19.09.27
영문 목차

영문목차

Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place

Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. There is a constant quest for delivering the lowest cost per cell which is keeping the innovation curve high. Single cell technology developers continue to attract funds from venture capitalists, making it one of the attractive areas to invest in the life science industry. While advancements in the hardware side are addressing throughput and low cost per cell, complexity in the data analysis remains unaddressed, which leaves opportunities to develop analytical tools and bioinformatics pipeline for single cell analysis data. From an application standpoint, while most of the current applications for single cell analysis are restricted to translational research, biopharma applications present the second largest opportunity. Single cell analysis for clinical applications is a long-term opportunity and the company that focuses more on addressing this application will clearly gain the first-mover advantage.

This study analysis the global single cell genomic and proteomic technologies and workflows and identifies key application areas and concepts that can help companies steer their way toward running a successful business. Documented insights from single cell biologists and researchers have been studied to identify current and future applications across translational, biopharma, clinical, and basic research. The study covers an assessment of the market across workflows, technologies, geographic regions and applications. These assessments have been developed after carefully studying 23 companies that are currently offering and developing solutions for single cell isolation and analytical purposes.

Key Issues Addressed:

Table of Contents

Executive Summary

Drivers & Restraints

Competitive Landscape

Funding Trends

Growth Opportunities and Companies to Action (C2A)

Revenue Forecast

Unmet Needs and Future Application Areas

Future Outlook

Appendix

The Frost & Sullivan Story

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기